Bausch Health Companies Inc (BHC) - Net Assets

Latest as of September 2025: CA$355.65 Million CAD ≈ $257.27 Million USD

Based on the latest financial reports, Bausch Health Companies Inc (BHC) has net assets worth CA$355.65 Million CAD (≈ $257.27 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$26.80 Billion ≈ $19.39 Billion USD) and total liabilities (CA$26.44 Billion ≈ $19.13 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Bausch Health Companies Inc's assets to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$355.65 Million
% of Total Assets	1.33%
Annual Growth Rate	N/A
5-Year Change	-153.22%
10-Year Change	-105.34%
Growth Volatility	169.34

Bausch Health Companies Inc - Net Assets Trend (1993–2024)

This chart illustrates how Bausch Health Companies Inc's net assets have evolved over time, based on quarterly financial data. Also explore BHC total asset value for the complete picture of this company's asset base.

Annual Net Assets for Bausch Health Companies Inc (1993–2024)

The table below shows the annual net assets of Bausch Health Companies Inc from 1993 to 2024. For live valuation and market cap data, see Bausch Health Companies Inc (BHC) total market value.

Year	Net Assets	Change
2024-12-31	CA$-322.00 Million ≈ $-232.93 Million	-292.68%
2023-12-31	CA$-82.00 Million ≈ $-59.32 Million	-131.54%
2022-12-31	CA$260.00 Million ≈ $188.08 Million	+864.71%
2021-12-31	CA$-34.00 Million ≈ $-24.60 Million	-105.62%
2020-12-31	CA$605.00 Million ≈ $437.65 Million	-46.74%
2019-12-31	CA$1.14 Billion ≈ $821.77 Million	-59.64%
2018-12-31	CA$2.81 Billion ≈ $2.04 Billion	-52.64%
2017-12-31	CA$5.94 Billion ≈ $4.30 Billion	+82.44%
2016-12-31	CA$3.26 Billion ≈ $2.36 Billion	-45.97%
2015-12-31	CA$6.03 Billion ≈ $4.36 Billion	+10.95%
2014-12-31	CA$5.43 Billion ≈ $3.93 Billion	+3.84%
2013-12-31	CA$5.23 Billion ≈ $3.79 Billion	+40.78%
2012-12-31	CA$3.72 Billion ≈ $2.69 Billion	-7.23%
2011-12-31	CA$4.01 Billion ≈ $2.90 Billion	-18.41%
2010-12-31	CA$4.91 Billion ≈ $3.55 Billion	+262.61%
2009-12-31	CA$1.35 Billion ≈ $979.73 Million	+12.71%
2008-12-31	CA$1.20 Billion ≈ $869.22 Million	-7.41%
2007-12-31	CA$1.30 Billion ≈ $938.82 Million	+1.01%
2006-12-31	CA$1.28 Billion ≈ $929.45 Million	-6.86%
2005-12-31	CA$1.38 Billion ≈ $997.94 Million	+1.56%
2004-12-31	CA$1.36 Billion ≈ $982.59 Million	+54.08%
2003-12-31	CA$881.60 Million ≈ $637.73 Million	+4.25%
2002-12-31	CA$845.69 Million ≈ $611.76 Million	-24.90%
2001-12-31	CA$1.13 Billion ≈ $814.58 Million	+374.22%
2000-12-31	CA$237.46 Million ≈ $171.77 Million	-45.45%
1999-12-31	CA$435.30 Million ≈ $314.89 Million	+750.20%
1998-12-31	CA$51.20 Million ≈ $37.04 Million	-32.19%
1997-12-31	CA$75.50 Million ≈ $54.62 Million	+104.61%
1996-12-31	CA$36.90 Million ≈ $26.69 Million	+152.74%
1995-12-31	CA$14.60 Million ≈ $10.56 Million	+89.61%
1994-12-31	CA$7.70 Million ≈ $5.57 Million	+396.15%
1993-12-31	CA$-2.60 Million ≈ $-1.88 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Bausch Health Companies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 980720000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	CA$10.49 Billion	%
Other Comprehensive Income	CA$-2.18 Billion	%
Other Components	CA$234.00 Million	%
Total Equity	CA$-1.28 Billion	100.00%

Bausch Health Companies Inc Competitors by Market Cap

The table below lists competitors of Bausch Health Companies Inc ranked by their market capitalization.

Company	Market Cap
Nanjing Sunlord Electronics Corporation LTD SHE:300975	$2.06 Billion
HeiLongJiang Kingland Technology Co Ltd SHE:000711	$2.06 Billion
Monadelphous Group Ltd AU:MND	$2.06 Billion
Henan Hanwei Electronics Co SHE:300007	$2.06 Billion
DCM Shriram Limited NSE:DCMSHRIRAM	$2.06 Billion
OCADO GROUP SP.ADR 1/2 F:0OC1	$2.05 Billion
Hunan Boyun New Materials Co Ltd SHE:002297	$2.05 Billion
Ascletis Pharma Inc F:2VJ	$2.05 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Bausch Health Companies Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from -1,022,000,000 to -1,279,000,000, a change of -257,000,000.
Net loss of 46,000,000 reduced equity.
Share repurchases of 26,000,000 reduced equity.
Other comprehensive income decreased equity by 298,000,000.
Other factors increased equity by 113,000,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CA$-46.00 Million	-3.6%
Share Repurchases	CA$26.00 Million	-2.03%
Other Comprehensive Income	CA$-298.00 Million	-23.3%
Other Changes	CA$113.00 Million	+8.84%
Total Change	CA$-	%

Book Value vs Market Value Analysis

This analysis compares Bausch Health Companies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1993-12-31	CA$-0.10	CA$7.67	x
1994-12-31	CA$0.09	CA$7.67	x
1995-12-31	CA$0.15	CA$7.67	x
1996-12-31	CA$0.37	CA$7.67	x
1997-12-31	CA$0.75	CA$7.67	x
1998-12-31	CA$0.48	CA$7.67	x
1999-12-31	CA$4.02	CA$7.67	x
2000-12-31	CA$1.65	CA$7.67	x
2001-12-31	CA$7.47	CA$7.67	x
2002-12-31	CA$5.27	CA$7.67	x
2003-12-31	CA$5.51	CA$7.67	x
2004-12-31	CA$8.44	CA$7.67	x
2005-12-31	CA$8.64	CA$7.67	x
2006-12-31	CA$8.03	CA$7.67	x
2007-12-31	CA$8.07	CA$7.67	x
2008-12-31	CA$7.52	CA$7.67	x
2009-12-31	CA$8.54	CA$7.67	x
2010-12-31	CA$25.08	CA$7.67	x
2011-12-31	CA$12.29	CA$7.67	x
2012-12-31	CA$12.17	CA$7.67	x
2013-12-31	CA$15.95	CA$7.67	x
2014-12-31	CA$15.56	CA$7.67	x
2015-12-31	CA$17.02	CA$7.67	x
2016-12-31	CA$9.08	CA$7.67	x
2017-12-31	CA$16.63	CA$7.67	x
2018-12-31	CA$7.81	CA$7.67	x
2019-12-31	CA$3.02	CA$7.67	x
2020-12-31	CA$1.51	CA$7.67	x
2021-12-31	CA$-0.30	CA$7.67	x
2022-12-31	CA$-1.91	CA$7.67	x
2023-12-31	CA$-2.80	CA$7.67	x
2024-12-31	CA$-3.48	CA$7.67	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Bausch Health Companies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -0.48%
• Asset Turnover: 0.36x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-2.13%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1993	0.00%	35.14%	0.48x	0.00x	CA$4.38 Million
1994	123.38%	54.91%	0.68x	3.32x	CA$8.73 Million
1995	40.41%	28.64%	0.34x	4.17x	CA$4.44 Million
1996	61.52%	34.19%	1.13x	1.59x	CA$19.01 Million
1997	46.62%	42.72%	0.88x	1.24x	CA$27.65 Million
1998	88.67%	40.25%	0.56x	3.90x	CA$40.28 Million
1999	14.36%	35.41%	0.28x	1.46x	CA$18.97 Million
2000	-62.32%	-47.86%	0.28x	4.66x	CA$-171.72 Million
2001	7.77%	14.99%	0.44x	1.18x	CA$-25.16 Million
2002	10.38%	11.14%	0.43x	2.17x	CA$3.23 Million
2003	-3.09%	-3.31%	0.43x	2.18x	CA$-115.42 Million
2004	3.88%	5.95%	0.44x	1.48x	CA$-83.08 Million
2005	6.45%	9.52%	0.43x	1.59x	CA$-48.93 Million
2006	15.87%	19.05%	0.49x	1.69x	CA$75.45 Million
2007	15.07%	23.20%	0.47x	1.37x	CA$65.76 Million
2008	16.64%	26.40%	0.47x	1.35x	CA$79.74 Million
2009	13.03%	21.51%	0.40x	1.53x	CA$41.02 Million
2010	-4.24%	-17.62%	0.11x	2.20x	CA$-699.30 Million
2011	3.98%	6.48%	0.19x	3.28x	CA$-241.14 Million
2012	-3.12%	-3.27%	0.20x	4.83x	CA$-487.76 Million
2013	-16.92%	-15.01%	0.21x	5.46x	CA$-1.38 Billion
2014	17.20%	11.05%	0.31x	4.96x	CA$382.28 Million
2015	-4.50%	-2.54%	0.21x	8.28x	CA$-857.30 Million
2016	-76.43%	-24.90%	0.22x	13.81x	CA$-2.72 Billion
2017	41.10%	27.56%	0.23x	6.41x	CA$1.82 Billion
2018	-151.77%	-49.50%	0.31x	10.04x	CA$-4.42 Billion
2019	-167.73%	-20.73%	0.25x	31.86x	CA$-1.89 Billion
2020	-104.49%	-6.96%	0.26x	58.32x	CA$-612.50 Million
2021	0.00%	-11.11%	0.29x	0.00x	CA$-926.40 Million
2022	0.00%	-2.61%	0.32x	0.00x	CA$-142.80 Million
2023	0.00%	-6.76%	0.32x	0.00x	CA$-489.80 Million
2024	0.00%	-0.48%	0.36x	0.00x	CA$81.90 Million

Industry Comparison

This section compares Bausch Health Companies Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $240,672,647
Average return on equity (ROE) among peers: -43.43%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Bausch Health Companies Inc (BHC)	CA$355.65 Million	0.00%	74.35x	$2.06 Billion
Aurora Cannabis Inc (ACB)	$601.87 Million	-11.52%	0.39x	$193.63 Million
Amotiv Limited (AOV)	$915.11 Million	1.59%	0.43x	$553.67 Million
Aequus Pharmaceuticals Inc (AQS)	$-4.29 Million	0.00%	0.00x	$479.73K
Avicanna Inc (AVCN)	$841.07K	-309.08%	1.52x	$13.17 Million
Avant Brands Inc (AVNT)	$-490.96K	0.00%	0.00x	$4.13 Million
CanadaBis Capital Inc (CANB)	$150.00K	0.00%	0.00x	$1.53 Million
Cannabist Company Holdings Inc (CBST)	$550.08 Million	-25.79%	1.50x	$12.59 Million
Cipher Pharmaceuticals Inc (CPH)	$80.52 Million	25.31%	0.07x	$326.62 Million
Cardiol Therapeutics Inc Class A (CRDL)	$22.27 Million	-71.36%	0.11x	$148.65 Million

About Bausch Health Companies Inc

TO:BHC Canada Drug Manufacturers - Specialty & Generic

Market Cap

$2.06 Billion

CA$2.84 Billion CAD

Market Cap Rank

#6148 Global

#196 in Canada

Share Price

CA$7.67

Change (1 day)

-1.54%

52-Week Range

CA$6.12 - CA$11.52

All Time High

CA$213.05